CA2144936A1 - Antibody conjugates with improved properties - Google Patents
Antibody conjugates with improved propertiesInfo
- Publication number
- CA2144936A1 CA2144936A1 CA002144936A CA2144936A CA2144936A1 CA 2144936 A1 CA2144936 A1 CA 2144936A1 CA 002144936 A CA002144936 A CA 002144936A CA 2144936 A CA2144936 A CA 2144936A CA 2144936 A1 CA2144936 A1 CA 2144936A1
- Authority
- CA
- Canada
- Prior art keywords
- antibody
- conjugate
- carrier protein
- conjugate according
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/6415—Toxins or lectins, e.g. clostridial toxins or Pseudomonas exotoxins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP94810173.8 | 1994-03-21 | ||
EP94810173 | 1994-03-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2144936A1 true CA2144936A1 (en) | 1995-09-22 |
Family
ID=8218230
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002144936A Abandoned CA2144936A1 (en) | 1994-03-21 | 1995-03-17 | Antibody conjugates with improved properties |
Country Status (11)
Country | Link |
---|---|
JP (1) | JPH0820545A (fi) |
KR (1) | KR950031111A (fi) |
AU (1) | AU1481795A (fi) |
CA (1) | CA2144936A1 (fi) |
FI (1) | FI951276A (fi) |
HU (1) | HUT71776A (fi) |
IL (1) | IL113022A (fi) |
NO (1) | NO951061L (fi) |
NZ (1) | NZ270734A (fi) |
RU (1) | RU95104325A (fi) |
ZA (1) | ZA952269B (fi) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2865737B1 (fr) * | 2004-02-03 | 2006-03-31 | Anteis Sa | Gel reticule biocompatible |
-
1995
- 1995-02-24 HU HU9500586A patent/HUT71776A/hu unknown
- 1995-03-14 AU AU14817/95A patent/AU1481795A/en not_active Abandoned
- 1995-03-17 FI FI951276A patent/FI951276A/fi unknown
- 1995-03-17 RU RU95104325/14A patent/RU95104325A/ru unknown
- 1995-03-17 IL IL11302295A patent/IL113022A/xx not_active IP Right Cessation
- 1995-03-17 NZ NZ270734A patent/NZ270734A/en unknown
- 1995-03-17 JP JP7059022A patent/JPH0820545A/ja active Pending
- 1995-03-17 CA CA002144936A patent/CA2144936A1/en not_active Abandoned
- 1995-03-20 KR KR1019950005739A patent/KR950031111A/ko not_active Application Discontinuation
- 1995-03-20 ZA ZA952269A patent/ZA952269B/xx unknown
- 1995-03-20 NO NO951061A patent/NO951061L/no unknown
Also Published As
Publication number | Publication date |
---|---|
IL113022A0 (en) | 1995-06-29 |
AU1481795A (en) | 1995-09-28 |
FI951276A (fi) | 1995-09-22 |
ZA952269B (en) | 1995-09-21 |
HU9500586D0 (en) | 1995-04-28 |
FI951276A0 (fi) | 1995-03-17 |
JPH0820545A (ja) | 1996-01-23 |
HUT71776A (en) | 1996-01-29 |
KR950031111A (ko) | 1995-12-18 |
IL113022A (en) | 2000-02-29 |
NZ270734A (en) | 1997-05-26 |
RU95104325A (ru) | 1996-12-27 |
NO951061D0 (no) | 1995-03-20 |
NO951061L (no) | 1995-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4400376A (en) | Immunological preparations | |
US5019387A (en) | Production of antibodies to HIV | |
US5013548A (en) | Production of antibodies to HIV | |
AU668870B2 (en) | Targeted delivery of genes encoding immunogenic proteins | |
US4950480A (en) | Enhancement of antigen immunogenicity | |
CN100586481C (zh) | 用于治疗或预防尼古丁成瘾的半抗原-载体偶联物 | |
KR100498198B1 (ko) | 알레르기에 대한 백신접종 및 치료를 위한 펩티드 임뮤노겐 | |
RU2120805C1 (ru) | Вакцина, обладающая способностью вызывать иммунный ответ против собственного jge организма, способ получения вакцины и способ иммунизации млекопитающего против опосредуемых jge аллергических реакций | |
EP0467714A1 (en) | The class II protein of the outer membrane of neisseria meningitidis | |
CN101557821A (zh) | 作为疟疾疫苗的恶性疟原虫表面蛋白的偶联物 | |
RU2253655C2 (ru) | Антиидиотипическое антитело к антителам, ингибирующим связывание иммуноглобулина с его высокоаффинным рецептором | |
US5601826A (en) | Peptide which produces protective immunity against tetanus | |
AU624324B2 (en) | Conjugate malaria vaccine | |
EP0597838B1 (en) | Vaccine compositions | |
US20040030106A1 (en) | Novel compounds and process | |
EP0166548A2 (en) | Broad spectrum vaccine against gonorrhea | |
CA2144936A1 (en) | Antibody conjugates with improved properties | |
KR20020007313A (ko) | IgE의 C-엡실론-2 도메인으로부터 유도된 에피토프또는 미모토프, 이들의 길항제 및 이들의 치료학적 용도 | |
AU3798699A (en) | Antibody conjugates with improved properties | |
EP0674907A2 (en) | Conjugabes of a antibody and a carrier protein, useful for active immunotherapy | |
CA2262427A1 (en) | Conjugated peptides, immunological reagent containing same and use thereof for treatment of immunological disorders | |
US4622223A (en) | Broad spectrum vaccine against gonorrhea | |
NZ286599A (en) | use of protein antibody conjugate for stimulating an immune response | |
US5173293A (en) | Anti-T-cell antibodies as adjuvants | |
WO1994000487A1 (en) | Peptide which produces protective immunity against tetanus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued |